within Pharmacolibrary.Drugs.G_GenitoUrinarySystemAndSexHormones.G03A_HormonalContraceptivesForSystemicUse.G03AC01_Norethisterone;

model Norethisterone
  extends Pharmacolibrary.Pharmacokinetic.Models.PK_1C_enteral(
    weight = 70,
    F = 0.64,
    Cl = 9.722222222222221e-06,
    adminDuration = 600,
    adminMass = 0.5 / 1000000,
    adminCount = 1,
    Vd = 0.0040999999999999995,
    Cmin = 0.001,
    Cmax = 0.01,
    Ctox_peak = 0.02,
    Ctox_trough = 0.01,
    ka = 0.030000000000000002,
    Tlag = 10.200000000000001);

  annotation (Documentation(
    info       = "<html><body><table><tr><td>name:</td><td>Norethisterone</td></tr><tr><td>ATC code:</td><td>G03AC01</td></tr><td>route:</td><td>oral</td></tr>
    <tr><td>compartments:</td><td>1</td></tr>
    <tr><td>dosage:</td><td>0.5</td><td>mg</td></tr>
    <tr><td>volume of distribution:</td><td>4.1</td><td>L</td></tr>
    <tr><td>clearance:</td><td>0.5</td><td>L/h/kg</td></tr>
    <tr><td colspan='3'>other parameters in model implementation</td></tr>
    </table><p>Norethisterone (norethindrone) is a synthetic progestin hormone used in hormonal contraceptives, menstrual disorders, and hormone replacement therapy. It is approved and widely used for birth control and to treat conditions such as endometriosis and abnormal uterine bleeding.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters reported in healthy adult women after a single oral administration.</p><h4>References</h4><ol><li><p>Shi, YE, et al., &amp; Fotherby, K (1987). Pharmacokinetics of norethisterone in humans. <i>Contraception</i> 35(5) 465–475. DOI:<a href=\"https://doi.org/10.1016/0010-7824(87)90083-7\">10.1016/0010-7824(87)90083-7</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/3621943/\">https://pubmed.ncbi.nlm.nih.gov/3621943</a></p></li><li><p>Vose, CW, et al., &amp; Serlin, MJ (1979). Bioavailability and pharmacokinetics of norethisterone in women after oral doses of ethynodiol diacetate. <i>Contraception</i> 19(2) 119–127. DOI:<a href=\"https://doi.org/10.1016/s0010-7824(79)80024-4\">10.1016/s0010-7824(79)80024-4</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/428229/\">https://pubmed.ncbi.nlm.nih.gov/428229</a></p></li><li><p>Kiriwat, O, &amp; Fotherby, K (1983). Pharmacokinetics of oral contraceptive steroids after morning or evening administration. <i>Contraception</i> 27(2) 153–160. DOI:<a href=\"https://doi.org/10.1016/0010-7824(83)90086-0\">10.1016/0010-7824(83)90086-0</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/6851554/\">https://pubmed.ncbi.nlm.nih.gov/6851554</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>10/2026 Pharmacolibrary 26.09: model of Drugs.ATC.G.G03AC01 folded in (Drugs.ATC removed)</li><li>06/2025 Tomas Kulhanek, generated model from data extracted from PUBMED, DrugBank and LLM(GPT4.1)</li></ul></body></html>",
    experiment (StartTime = 0, StopTime = 86400, Tolerance = 1e-9, Interval = 1)
  ));
    
end Norethisterone;
